August 2025 Publications
- Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E-4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial. Dagnew AF, Han LL, Naidoo K, Fairlie L, Innes JC, Middelkoop K, Tameris M, Wilkinson RJ, Ananworanich J, Bower D, Schlehuber L, Frahm N, Cinar A, Dunne M, Schmidt AC. Lancet HIV. 2025 Aug;12(8):e546-e555. doi: 10.1016/S2352-3018(25)00124-9. Epub 2025 Jul 1.
- Distal airway epithelial progenitors mediate TGF-β release to drive lung CD8+ TRM induction following mucosal BCG vaccination. Blake JA, Seifert J, Miranda-Hernandez S, Ruscher R, Giacomin PR, Doolan DL, Kupz A. Mucosal Immunol. 2025 Aug;18(4):973-988. doi: 10.1016/j.mucimm.2025.05.007. Epub 2025 May 30.
- Self-assembled ferritin tuberculosis nanovaccines targeting ESAT-6 and CFP-10 elicit potent immunogenicity in mice. Guo F, Dong S, Song Y, Qian Y, Jiang H, Zhang W, Li B, Qian Z, Wang X, Xu G, Wang H, Xu T. Int J Biol Macromol. 2025 Aug;320(Pt 4):146101. doi: 10.1016/j.ijbiomac.2025.146101. Epub 2025 Jul 17.
- A Simple and Rapid Method of Probiotic Bacterial Ghost Cell Preparation to Deliver Mycobacterium tuberculosis Antigen. Aarthi Y, Anjana A, Tejal G, Shanmugaraja M, Ramadevi S, Princess R. Mol Biotechnol. 2025 Aug;67(8):3243-3254. doi: 10.1007/s12033-024-01260-0. Epub 2024 Aug 20.
- Prioritizing countries for TB vaccine readiness research using a global stakeholder-centric approach. Gill MM, Limaye R, Pelzer PT, Frick M, Kerkhoff AD. PLOS Glob Public Health. 2025 Aug 1;5(8):e0004668. doi: 10.1371/journal.pgph.0004668.
- NK cell-macrophage interactions in granulomas correlate with limited tuberculosis pathology. Niewold P, IJsselsteijn ME, Dijkman K, de Miranda N, Ottenhoff THM, Verreck FAW, Joosten SA. PLoS Pathog. 2025 Aug 1;21(8):e1012980. doi: 10.1371/journal.ppat.1012980.
- Macrophage Response to Avirulent and Virulent Mycobacterium tuberculosis and Anti-TB Effects of Exosome Treatment. Yang L, Lyu L, Li C, Zhang X, Ju Y, Zhang J, Liu J, Yue L, Ding N, Zhang X, Lu D, Yang T, Wang P, Wang J, Wang X, Xu S, Sheng Y, Jiang C, Wang J, Hu X, Bahetibieke T, Zhang Z, Chen F. Genomics Proteomics Bioinformatics. 2025 Aug 5:qzaf065. doi: 10.1093/gpbjnl/qzaf065. Epub ahead of print.
- Immunoinformatics analysis of the proteins MPT83 and MPT51 to design a possible chimeric vaccine against Mycobacterium tuberculosis. Loureiro RTO, Andrade SJT, do Carmo EJ, Higa AM, de Lima Procópio RE. Braz J Microbiol. 2025 Aug 6. doi: 10.1007/s42770-025-01755-1. Epub ahead of print.
- Prior appendectomy attenuates the immune protective efficacy of BCG vaccination against Mycobacterium tuberculosis infection. Huang H, Xu W, Xiong S. Immunobiology. 2025 Aug 8;230(5):153106. doi: 10.1016/j.imbio.2025.153106. Epub ahead of print.
- Generalized linear modeling of flow cytometry data to analyze immune responses in tuberculosis vaccine research. Maldonado P, Dutt TS, Hitpas A, Podell B, Anderson GB, Henao-Tamayo M. NPJ Syst Biol Appl. 2025 Aug 10;11(1):90. doi: 10.1038/s41540-025-00572-4.
- Characterization of PPE19 as a novel mediator of Mycobacterium tuberculosis-macrophage interactions. De Voss CJ, Riek SN, Stupar M, Tan L, Forde BM, West NP. mSphere. 2025 Aug 11:e0003625. doi: 10.1128/msphere.00036-25. Epub ahead of print.
- Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferon-gamma release assay-positive participants. Cobelens F, Pelzer PT, Churchyard GJ, Garcia-Basteiro A, Hatherill M, Hill PC, Martinez L, White RG. Vaccine. 2025 Aug 13;61:127301. doi: 10.1016/j.vaccine.2025.127301. Epub 2025 May 30.
- Recombinant BCGΔBCG1419c protects outbred mice against M. tuberculosis challenge. Kurtz SL, Gould V, Flores-Valdez MA, Elkins KL. Vaccine. 2025 Aug 13;61:127347. doi: 10.1016/j.vaccine.2025.127347. Epub 2025 Jun 3.
- Protective Efficacy of Subunit Vaccine Expressing Rv0976c Against Tuberculosis. Zhou Z, Chen D, Chen F, Xu W, Pan Z, Xiang Z, Gao X, Li Y, Zhong F, Liu J, Zhang L. Vaccines (Basel). 2025 Aug 17;13(8):872. doi: 10.3390/vaccines13080872.
- BCG Vaccine-Induced Innate and Adaptive Pulmonary Immunity Correlating with Protective Efficacy Against Mycobacterium tuberculosis in the Lungs. Khanna M, Ramsay AJ. Vaccines (Basel). 2025 Aug 19;13(8):876. doi: 10.3390/vaccines13080876.
- Host-intrinsic and host-extrinsic factors modulate immunity to Mtb infection, reinfection, and noncanonical vaccination routes. Bromley JD, Simonson AW, Shalek AK, Flynn JL. Cell Rep Med. 2025 Aug 19;6(8):102286. doi: 10.1016/j.xcrm.2025.102286. Epub 2025 Aug 7.
- Research progress of mRNA vaccines for infectious diseases. Zhang Z, Du J, Zhang D, Han R, Wu X, Liang Y. Eur J Med Res. 2025 Aug 23;30(1):792. doi: 10.1186/s40001-025-03060-x.
- Development and Preclinical Evaluation of Next-generation ΔsigH-based Live Candidate Vaccines. Arora G, Munson CW, Ahmed M, Shivanna V, Devi A, Devireddy VS, Antony B, Hall-Ursone S, Gonzalez OD, Dick E Jr, Jagannath C, Alvarez X, Mehra S, Khader SA, Singh DK, Kaushal D. JCI Insight. 2025 Aug 28:e195947. doi: 10.1172/jci.insight.195947. Epub ahead of print.
- Self-assembled ferritin nanoparticles using SpyCatcher/SpyTag multimerization of Mycobacterium tuberculosis TB10.4 protein induce potent immunogenicity. Guo F, Dong S, Song Y, Xiesihan G, Jiang H, Qian Z, Wang X, Wang H, Xu T. Int Immunopharmacol. 2025 Aug 28;161:115019. doi: 10.1016/j.intimp.2025.115019. Epub 2025 Jun 12.
- Driving innovation from discovery to access: Meeting report of the 7 th Global Forum on TB Vaccines (8-10 October 2024, Rio de Janeiro, Brazil). Palmer S, Clark RA, Connell BJ, Muwanga VM, Coelho A, Ogongo P, Young C. Gates Open Res. 2025 Aug 27;9:65. doi: 10.12688/gatesopenres.16360.1.
- Immunogenicity, biodistribution, and toxicology evaluation of Mycobacterium tuberculosis ag85a plasmid DNA in cynomolgus monkeys, mice and guinea pigs. Zhang D, Yang Y, Zhang Z, Zhang J, Wu X, Liang Y. J Immunol Methods. 2025 Aug 28:113969. doi: 10.1016/j.jim.2025.113969. Epub ahead of print.